HOUSTON, Sept. 22, 2021 /PRNewswire/ -- Cabot Oil
& Gas Corporation (NYSE: COG) ("Cabot") and Cimarex Energy Co.
(NYSE: XEC) ("Cimarex") today announced that, in connection
with the previously announced offers to eligible holders (as
defined herein) to exchange (each an "Exchange Offer" and
collectively, the "Exchange Offers") any and all outstanding notes
issued by Cimarex as set forth in the table below
(the "Existing Cimarex Notes") for (1) up to $2,000,000,000 aggregate principal amount of new
notes issued by Cabot (the "New Cabot Notes") and (2) cash, and
related consent solicitations by Cimarex (each, a "Consent
Solicitation" and, collectively, the "Consent Solicitations") to
adopt certain proposed amendments to each of the indentures
governing the Existing Cimarex Notes (the "Proposed Amendments"),
as of 5:00 p.m., New York City time, on September 21, 2021 (the "Early Tender Date"), the
following principal amounts of each series of Existing Cimarex
Notes have been validly tendered and not validly withdrawn (and
consents thereby validly given and not validly revoked):
Title of Series
of
Existing Cimarex
Notes
|
|
CUSIP Number
of Existing
Cimarex Notes
|
|
ISIN of
Existing
Cimarex Notes
|
|
Aggregate
Principal Amount
Outstanding
|
|
Existing Cimarex
Notes Tendered at Early
Tender Date
|
Principal
Amount
|
|
Percentage
|
4.375% Senior
Notes due 2024
|
|
171798AC5
|
|
US171798AC50
|
|
$750,000,000
|
|
$705,278,000
|
|
94.04%
|
|
|
|
|
|
|
|
|
|
|
|
3.90% Senior
Notes due 2027
|
|
171798AD3
|
|
US171798AD34
|
|
$750,000,000
|
|
$685,455,000
|
|
91.39%
|
|
|
|
|
|
|
|
|
|
|
|
4.375% Senior
Notes due 2029
|
|
171798AE1
|
|
US171798AE17
|
|
$500,000,000
|
|
$432,669,000
|
|
86.53%
|
In addition, Cimarex has received the requisite number of
consents to adopt the Proposed Amendments with respect to each of
the three outstanding series of Existing Cimarex Notes that are
subject to the Exchange Offers and Consent Solicitations. Cimarex
has entered into a supplemental indenture with the trustee for each
such outstanding series of Existing Cimarex Notes (each, a
"Supplemental Indenture") effecting the Proposed Amendments.
Withdrawal rights for the Exchange Offers and Consent
Solicitations expired as of the Early Tender Date.
The Exchange Offers and Consent Solicitations are being made
pursuant to the terms and subject to the conditions set forth in
the offering memorandum and consent solicitation statement dated as
of September 8, 2021 (as it may be
amended or supplemented, the "Offering Memorandum and Consent
Solicitation Statement"). Each Exchange Offer and Consent
Solicitation is conditioned upon the completion of the other
Exchange Offers and Consent Solicitations, although Cabot may waive
such condition at any time with respect to an Exchange Offer.
Any waiver of a condition by Cabot with respect to an
Exchange Offer will automatically waive such condition with respect
to the corresponding Consent Solicitation.
In addition, the Exchange Offers and Consent Solicitations are
conditioned upon the consummation of the merger transaction
contemplated by the Agreement and Plan of Merger, dated as of
May 23, 2021, as amended on
June 29, 2021 (as it may be further
amended from time to time, the "Merger Agreement"), among Cabot,
Double C Merger Sub, Inc., a wholly owned subsidiary of Cabot
("Merger Sub"), and Cimarex, pursuant to which Merger Sub will
merge with and into Cimarex (the "Merger"), with Cimarex surviving
the Merger as a wholly owned subsidiary of Cabot. Cabot, in
its sole discretion, may terminate, withdraw, amend or extend any
of the Exchange Offers and may extend the Expiration Date (as
defined herein) with respect to the Exchange Offers, subject to the
terms and conditions set forth in the Offering Memorandum and
Consent Solicitation Statement. Any such termination,
withdrawal, amendment or extension by Cabot will automatically
terminate, withdraw, amend or extend the corresponding Consent
Solicitation, as applicable.
The Exchange Offers and Consent Solicitations will expire at
11:59 p.m., New York City time, on October 5, 2021, unless extended (the "Expiration
Date"). Holders who validly tender (and do not validly withdraw)
their Existing Cimarex Notes after the Early Tender Date but at or
before the Expiration, will be eligible to receive, on the
settlement date, the applicable Exchange Consideration as defined
in and set out in the Offering Memorandum and Consent Solicitation
Statement. The settlement date will be promptly after the
Expiration Date and is expected to be within two business days
after the Expiration Date.
The Exchange Offers and Consent Solicitations are only being
made, and documents relating to the Exchange Offers and Consent
Solicitations are only being distributed, to holders of Existing
Cimarex Notes who complete and return an eligibility letter
confirming that they are persons (a) in the United States who are reasonably believed
to be "qualified institutional buyers" as defined in Rule 144A
under the Securities Act of 1933, as amended (the "Securities
Act"), or (b) that are outside the United
States who are not "U.S. persons" as defined in Rule 902
under the Securities Act and who are eligible to participate in the
Exchange Offer pursuant to the laws of the applicable jurisdiction,
as set forth in the eligibility letter ("eligible holders").
The complete terms and conditions of the Exchange Offers and
Consent Solicitations are described in the Offering Memorandum
and Consent Solicitation Statement, a copy of which may be obtained
by contacting D.F. King & Co., Inc., the exchange agent and
information agent in connection with the Exchange Offers and
Consent Solicitations, at (800) 714-3311 (U.S. toll-free) or (212)
269-5550 (banks and brokers) or cimarex@dfking.com. The
eligibility letter is available electronically at:
www.dfking.com/cimarex.
This press release does not constitute an offer to sell or
purchase, or a solicitation of an offer to sell or purchase, or the
solicitation of tenders or consents with respect to, any security.
No offer, solicitation, purchase or sale will be made in any
jurisdiction in which such an offer, solicitation, or sale would be
unlawful. The Exchange Offers and Consent Solicitations are
being made to eligible holders solely pursuant to the Offering
Memorandum and Consent Solicitation Statement and only to such
persons and in such jurisdictions as is permitted under applicable
law.
The New Cabot Notes have not been registered under the
Securities Act or any state or foreign securities laws.
Therefore, the New Cabot Notes may not be offered or sold in
the United States or to any U.S.
person absent registration, except pursuant to an applicable
exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act.
About Cabot
Cabot Oil & Gas Corporation, headquartered in Houston, Texas is a leading independent
natural gas producer, with its entire resource base located in the
continental United States.
About Cimarex
Cimarex Energy Co. is an independent oil and gas exploration and
production company with principal operations in the Permian Basin
and Mid-Continent areas of the U.S.
Cautionary Statement Regarding Forward-Looking
Information
This press release includes forward-looking statements within
the meaning of federal securities laws. All statements, other
than statements of historical fact, included in this press release
are forward-looking statements. Such forward-looking
statements include, but are not limited to, statements about the
proposed Merger. No assurances can be given that
the forward-looking statements contained in this press release will
occur as expected and actual results may differ materially from
those included in this press release. Forward-looking
statements are based on current expectations assumptions that
involve a number of risks and uncertainties that could cause actual
results to differ materially from those included in this press
release. These risks and uncertainties include, without
limitation: the ability to obtain the requisite Cabot and Cimarex
stockholder approvals to consummate the Merger; the risk that an
event, change or other circumstances could give rise to the
termination of the Merger, which would constitute the failure of a
condition to the Exchange Offers and Consent Solicitations; and the
risk that a condition to closing of the Merger may not be satisfied
on a timely basis or at all. Additional important risks,
uncertainties and other factors are described in the Offering
Memorandum and Consent Solicitation Statement, Cabot's Annual
Report on Form 10-K for the year ended December 31, 2020 and Cabot's Quarterly Reports
on Form 10-Q for the quarterly periods ended March 31, 2021 and June
30, 2021, Current Reports on Form 8-K and other filings
Cabot makes with the Securities and Exchange Commission (the "SEC")
and in Cimarex's Annual Report on Form 10-K for the year ended
December 31, 2020 and Cimarex's
Quarterly Reports on Form 10-Q for the quarterly periods ended
March 31, 2021 and June 30, 2021, Current Reports on Form 8-K and
other filings Cimarex makes with the SEC. Forward-looking
statements are based on the estimates and opinions of management at
the time the statements are made. Except to the extent
required by applicable law, neither Cabot nor Cimarex undertakes
any obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise. You are cautioned not to place undue reliance on
these forward-looking statements that speak only as of the date
hereof.
Additional Information about the Merger and Where to Find
It
In connection with the proposed Merger, Cabot filed with the SEC
a registration statement on Form S-4 on June
30, 2021 (as amended on August 13,
2021), that includes a joint proxy statement of Cabot and
Cimarex and that also constitutes a prospectus of Cabot. The
registration statement was declared effective by the SEC on
August 20, 2021, and on August 23, 2021 Cabot and Cimarex each filed the
definitive joint proxy statement/prospectus in connection with the
proposed Merger with the SEC. Cabot and Cimarex commenced
mailing the definitive joint proxy statement/prospectus to
stockholders on or about August 23,
2021. Each of Cabot and Cimarex will also file other
relevant documents with the SEC regarding the proposed Merger.
This press release is not a substitute for the registration
statement, the definitive joint proxy statement/prospectus or any
other document that Cabot or Cimarex has filed or may file with the
SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE
REGISTRATION STATEMENT, THE DEFINITIVE JOINT PROXY
STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE
FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO
THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY
CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CABOT, CIMAREX
AND THE PROPOSED MERGER. Investors and security holders are
able to obtain free copies of the registration statement, the
definitive joint proxy statement/prospectus and all other documents
containing important information about Cabot, Cimarex and the
proposed Merger, once such documents are filed with the SEC through
the website maintained by the SEC at http://www.sec.gov.
Copies of the documents filed with the SEC by Cabot may be obtained
free of charge on Cabot's website at
www.cabotog.com/investor-relations. Copies of the documents
filed with the SEC by Cimarex may be obtained free of charge on
Cimarex's website at www.cimarex.com/investor-relations.
Participants in the Solicitation
Cabot, Cimarex and certain of their respective directors and
executive officers may be deemed to be participants in the
solicitation of proxies in respect of the proposed Merger.
Information about the directors and executive officers of
Cabot, including a description of their direct or indirect
interests, by security holdings or otherwise, is set forth in
Cabot's proxy statement for its 2021 Annual Meeting of
Stockholders, which was filed with the SEC on March 12, 2021, and Cabot's Annual Report on Form
10-K for the year ended December 31,
2020, which was filed with the SEC on February 26, 2021. Information about the
directors and executive officers of Cimarex, including a
description of their direct or indirect interests, by security
holdings or otherwise, is set forth in Cimarex's proxy statement
for its 2021 Annual Meeting of Stockholders, which was filed with
the SEC on March 26, 2021, and
Cimarex's Annual Report on Form 10-K for the year ended
December 31, 2020, which was filed
with the SEC on February 23, 2021.
Investors may obtain additional information regarding the
interests of those persons and other persons who may be deemed
participants in the proposed Merger by reading the definitive joint
proxy statement/prospectus and other relevant materials to be filed
with the SEC regarding the proposed Merger when such materials
become available. Investors should read the definitive joint
proxy statement/prospectus carefully before making any voting or
investment decisions. You may obtain free copies of these
documents from Cabot or Cimarex using the sources indicated
above.
View original
content:https://www.prnewswire.com/news-releases/cabot-oil--gas-and-cimarex-energy-announce-results-of-early-participation-in-private-exchange-offers-and-consent-solicitations-301382211.html
SOURCE Cabot Oil & Gas Corporation; Cimarex Energy Co.